| Mr Pratap Aravapalli, MD | |
|
401 S Ballenger Hwy, Flint, MI 48532 | |
| (810) 720-1730 | |
| (810) 720-1736 |
| Full Name | Mr Pratap Aravapalli |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 46 Years |
| Location | 401 S Ballenger Hwy, Flint, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659420743 | NPI | - | NPPES |
| 2633934 | Medicaid | MI | |
| 0996930 | Other | HEALTH PLUS OF MICHIGAN | |
| M001301 | Other | TRICARE REGION 2 AND 5 | |
| 050B560430 | Other | BLUE CROSS BLUE SHIELD | |
| AN250004 | Other | MCARE INC | |
| PA054639 | Other | STATE LICENSE NUMBER | |
| 252505 | Other | MCLAREN HEALTH ADVANTAG | |
| 252505 | Other | MCLAREN HEALTH PLAN | |
| 050B560430 | Other | BLUE CARE NETWORK | |
| 103621 | Other | GREAT LAKES HEALTH PLAN | |
| 1172870001 | Other | THE WELLNESS PLAN | |
| 567562 | Other | SELECT C ARE | |
| 0B56043013 | Other | PERSONAL IDENTIFICATION | |
| 30946 | Other | COMMUNITY CHOICE OF MI M | |
| 4647093 | Other | AETNA HEALTH CARE | |
| EM033063 | Other | HEALTH ALLIANCE PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301054639 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Flint | Flint, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Services Associates Pc | 4385557602 | 63 |
News Archive
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.
The researchers reported that the Wurn Technique(R) (patent pending) is highly effective at increasing fertility in both natural conception and in vitro fertilization (IVF). The therapy uses neither drugs nor surgery.
Parents spend hours planning to talk with their children about the "birds and bees." But moms and dads often ignore an equally important conversation-;discussing their family's overall health history.
Current users of medical device technologies for orthopaedic applications seek systems that offer maximum comfort while requiring minimum physical supervision. This is driving the market to continuously evolve technologies that use radically different approaches or make significant improvements to existing products.
› Verified 4 days ago
| Entity Name | Anesthesia Services Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497797153 PECOS PAC ID: 4385557602 Enrollment ID: O20031111000822 |
News Archive
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.
The researchers reported that the Wurn Technique(R) (patent pending) is highly effective at increasing fertility in both natural conception and in vitro fertilization (IVF). The therapy uses neither drugs nor surgery.
Parents spend hours planning to talk with their children about the "birds and bees." But moms and dads often ignore an equally important conversation-;discussing their family's overall health history.
Current users of medical device technologies for orthopaedic applications seek systems that offer maximum comfort while requiring minimum physical supervision. This is driving the market to continuously evolve technologies that use radically different approaches or make significant improvements to existing products.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Pratap Aravapalli, MD 1051 Professional Drive, Flint, MI 48532 Ph: (810) 720-1730 | Mr Pratap Aravapalli, MD 401 S Ballenger Hwy, Flint, MI 48532 Ph: (810) 720-1730 |
News Archive
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.
The researchers reported that the Wurn Technique(R) (patent pending) is highly effective at increasing fertility in both natural conception and in vitro fertilization (IVF). The therapy uses neither drugs nor surgery.
Parents spend hours planning to talk with their children about the "birds and bees." But moms and dads often ignore an equally important conversation-;discussing their family's overall health history.
Current users of medical device technologies for orthopaedic applications seek systems that offer maximum comfort while requiring minimum physical supervision. This is driving the market to continuously evolve technologies that use radically different approaches or make significant improvements to existing products.
› Verified 4 days ago
James T Hiscock, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Hurley Plaza, Flint, MI 48503 Phone: 810-262-9953 Fax: 810-760-0440 | |
Gayle Lourens, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Hurley Plz, Flint, MI 48503 Phone: 810-262-9967 | |
Mr. Eranio U Malto, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-720-1730 Fax: 810-720-1736 | |
Dr. Vincent E Rampersaud, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4800 S Saginaw St, Suite 1800, Flint, MI 48507 Phone: 810-732-8336 | |
Siva Kumar Sripada, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4800 S Saginaw St, Suite 1815, Flint, MI 48507 Phone: 810-275-9152 Fax: 810-213-0228 | |
Ms. Jane Nithya Tolson Solomons, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 4800 S Saginaw St, Flint, MI 48507 Phone: 810-275-9333 | |
Mr. Ashvin A Patel, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-720-1730 Fax: 810-720-1736 |